Status and phase
Conditions
Treatments
About
Background
Preventive antibiotic treatment before performing invasive procedures is a basic element in preventing infections. The essence of preventive antibiotic treatment is strengthening the defense mechanisms of the immune system by preserving a certain drug levels in the blood. The timing of giving the antibiotics is very important. Several research groups have tried to check the levels of Cefazolin (the most common antibiotics in the field of obstetrics) in serum and adipose tissue in women during cesarean. These groups presented conflicting research results.
OBJECTIVE
This study will discuss the preventive antibiotic treatment levels accepted prior cesareans, to determine:
Full description
Background
Preventive antibiotic treatment before performing invasive procedures is a basic element in preventing infections. The essence of preventive antibiotic treatment is strengthening the defense mechanisms of the immune system by preserving a certain drug levels in the blood. The timing of giving the antibiotics is very important. Several research groups have tried to check the levels of Cefazolin (the most common antibiotics in the field of obstetrics) in serum and adipose tissue in women during cesarean. These groups presented conflicting research results.
OBJECTIVE
This study will discuss the preventive antibiotic treatment levels accepted prior cesareans, to determine:
PATIENTS & METHODS
Women that meet the inclusion criteria and are about to undergo cesarean in different indications, in elective and urgent way.
With the results of tissue and serum samples, segmentation which compares the drug levels in the different tissues will be performed.Also, the correlation between drug levels in women with different BMI and morbidities that may cause measurable or not pharmacokinetic changes will be examined.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
250 participants in 1 patient group
Loading...
Central trial contact
Yariv Yogev, professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal